| 1 |
31205728 |
10.1136/lupus-2019-000324 |
2022 |
Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival. |
FOXP1 |
| 2 |
31404445 |
10.1007/s12308-019-00354-y |
2022 |
Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas. |
FOXP1 |
| 3 |
33830472 |
10.1007/s13258-021-01094-z |
2022 |
CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p. |
FOXP1 |
| 4 |
35098439 |
10.1007/s11010-021-04335-7 |
2022 |
LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway. |
FOXP1 |
| 5 |
35165282 |
10.1038/s41467-022-28479-2 |
2022 |
EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. |
FOXP1 |
| 6 |
31631728 |
10.1080/10428194.2019.1675877 |
2021 |
The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignancies. |
FOXP1 |
| 7 |
31850910 |
10.1097/PAI.0000000000000813 |
2021 |
Correlation Analysis Between the Expression of MEF2B, and Germinal Center and Nongerminal Center Markers in Diffuse Large B-Cell Lymphoma. |
FOXP1 |
| 8 |
31918459 |
10.1002/cam4.2829 |
2021 |
OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma. |
FOXP1 |
| 9 |
33095438 |
10.1007/s11064-020-03151-7 |
2021 |
Circular RNA Circ_ANKMY2 Regulates Temporal Lobe Epilepsy Progression via the miR-106b-5p/FOXP1 Axis. |
FOXP1 |
| 10 |
30938769 |
10.1093/labmed/lmz008 |
2020 |
BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use. |
FOXP1 |
| 11 |
31352982 |
10.1016/j.path.2019.03.012 |
2020 |
Prognostic and Predictive Biomarkers in Diffuse Large B-cell Lymphoma. |
FOXP1 |
| 12 |
31605845 |
10.1016/j.wneu.2019.09.158 |
2020 |
Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation. |
FOXP1 |
| 13 |
31648327 |
10.1182/bloodadvances.2019000210 |
2020 |
Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma. |
FOXP1 |
| 14 |
31751845 |
10.1016/j.anndiagpath.2019.151421 |
2020 |
The life and death of the germinal center. |
FOXP1 |
| 15 |
32309216 |
10.3389/fonc.2020.00448 |
2020 |
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model. |
FOXP1 |
| 16 |
32534365 |
10.1016/j.leukres.2020.106399 |
2020 |
t(3;14)(p14.1;q32)/FOXP1-IGH translocation in thyroid extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). |
FOXP1 |
| 17 |
32765691 |
10.3892/etm.2020.8940 |
2020 |
mRNA expression profile analysis reveals a C-MYC/miR-34a pathway involved in the apoptosis of diffuse large B-cell lymphoma cells induced by Yiqichutan treatment. |
FOXP1 |
| 18 |
33261009 |
10.3390/cancers12123546 |
2020 |
MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth. |
FOXP1 |
| 19 |
28471196 |
|
2019 |
[The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma]. |
FOXP1 |
| 20 |
29097500 |
10.3324/haematol.2017.179309 |
2019 |
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma. |
FOXP1 |
| 21 |
29122756 |
10.1182/blood-2017-08-799080 |
2019 |
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy. |
FOXP1 |
| 22 |
29507076 |
10.1182/bloodadvances.2017014704 |
2019 |
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. |
FOXP1 |
| 23 |
29615404 |
10.1182/blood-2017-10-810630 |
2019 |
The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma. |
FOXP1 |
| 24 |
30213873 |
10.1182/blood-2018-06-855502 |
2019 |
<i>miR-150</i> downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. |
FOXP1 |
| 25 |
30402490 |
10.1155/2018/6728128 |
2019 |
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion. |
FOXP1 |
| 26 |
30715765 |
10.1111/his.13832 |
2019 |
Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases. |
FOXP1 |
| 27 |
30975638 |
10.1182/blood.2018889931 |
2019 |
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas. |
FOXP1 |
| 28 |
31686194 |
10.1007/s00428-019-02681-y |
2019 |
Novel markers in pediatric-type follicular lymphoma. |
FOXP1 |
| 29 |
27224915 |
10.18632/oncotarget.9507 |
2018 |
FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures. |
FOXP1 |
| 30 |
27457567 |
10.1038/srep30437 |
2018 |
Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysis. |
FOXP1 |
| 31 |
27588474 |
10.18632/oncotarget.11688 |
2018 |
Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia. |
FOXP1 |
| 32 |
27678023 |
10.1080/10428194.2016.1228932 |
2018 |
The significance of FOXP1 in diffuse large B-cell lymphoma. |
FOXP1 |
| 33 |
27924626 |
10.14670/HH-11-852 |
2018 |
Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas. |
FOXP1 |
| 34 |
29507226 |
10.1073/pnas.1711335115 |
2018 |
Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells. |
FOXP1 |
| 35 |
26332259 |
10.1111/his.12854 |
2017 |
IgG4-positive extranodal marginal zone lymphoma arising in Hashimoto's thyroiditis: clinicopathological and cytogenetic features of a hitherto undescribed condition. |
FOXP1 |
| 36 |
26799990 |
10.1002/hon.2280 |
2017 |
Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling. |
FOXP1 |
| 37 |
27056922 |
10.3324/haematol.2016.142141 |
2017 |
N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. |
FOXP1 |
| 38 |
27775850 |
10.1111/his.13106 |
2017 |
Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS). |
FOXP1 |
| 39 |
27806315 |
10.18632/oncotarget.12988 |
2017 |
Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting. |
FOXP1 |
| 40 |
27861791 |
10.1002/eji.201646373 |
2017 |
FOXP1 is a regulator of quiescence in healthy human CD4<sup>+</sup> T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders. |
FOXP1 |
| 41 |
27909217 |
10.3324/haematol.2016.156455 |
2017 |
The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells. |
FOXP1 |
| 42 |
28001444 |
10.1210/en.2016-1802 |
2017 |
Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D. |
FOXP1 |
| 43 |
28056299 |
10.3760/cma.j.issn.0529-5807.2016.12.006 |
2017 |
[Application of rabbit monoclonal antibody GCET2 in diagnosis of diffuse large B cell lymphoma]. |
FOXP1 |
| 44 |
28155972 |
10.5114/pjp.2016.63775 |
2017 |
[A rare CD5-positive subgroup of diffuse large B-cell lymphoma - clinical, morphological and immunophenotypic features in Polish patients]. |
FOXP1 |
| 45 |
28219927 |
10.15252/embj.201695495 |
2017 |
Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia. |
FOXP1 |
| 46 |
25650440 |
10.1126/scisignal.2005654 |
2016 |
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma. |
FOXP1 |
| 47 |
25966160 |
10.4238/2015.April.27.3 |
2016 |
Immunohistochemical subtypes of diffuse large B-cell lymphoma in the head and neck region. |
FOXP1 |
| 48 |
26071053 |
10.1186/s13045-015-0168-7 |
2016 |
Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study. |
FOXP1 |
| 49 |
26289642 |
10.1182/blood-2015-02-626176 |
2016 |
The forkhead transcription factor FOXP1 represses human plasma cell differentiation. |
FOXP1 |
| 50 |
26308769 |
10.1038/leu.2015.237 |
2016 |
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. |
FOXP1 |
| 51 |
26341140 |
10.1016/j.yexmp.2015.08.019 |
2016 |
Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP. |
FOXP1 |
| 52 |
26500140 |
10.1038/leu.2015.299 |
2016 |
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas. |
FOXP1 |
| 53 |
26729899 |
10.1182/blood-2015-08-662635 |
2016 |
The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling. |
FOXP1 |
| 54 |
26762526 |
10.1007/s00428-015-1902-9 |
2016 |
Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of germinotropic lymphoproliferative disorder. |
FOXP1 |
| 55 |
26780579 |
10.1111/ajt.13558 |
2016 |
EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features. |
FOXP1 |
| 56 |
26787899 |
10.1073/pnas.1524677113 |
2016 |
Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1. |
FOXP1 |
| 57 |
26854484 |
10.1016/j.exphem.2015.12.007 |
2016 |
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma. |
FOXP1 |
| 58 |
26881530 |
10.4103/0973-1482.144357 |
2016 |
Immunological subtypes analysis of Uygur diffuse large B-cell lymphoma in Xinjiang and their prognostic significance. |
FOXP1 |
| 59 |
26898077 |
|
2016 |
FOXP1 Expression in Normal and Neoplastic Erythroid and Myeloid Cells. |
FOXP1 |
| 60 |
26989186 |
10.1182/blood-2016-01-692129 |
2016 |
S1PR2 deficiency in DLBCL: a FOXy connection. |
FOXP1 |
| 61 |
24232982 |
10.1007/s10120-013-0313-3 |
2015 |
Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. |
FOXP1 |
| 62 |
24634383 |
10.1158/1078-0432.CCR-13-1597 |
2015 |
EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations. |
FOXP1 |
| 63 |
24887414 |
10.1371/journal.pone.0098169 |
2015 |
Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma. |
FOXP1 |
| 64 |
25043849 |
10.1002/gcc.22204 |
2015 |
Deregulated FOX genes in Hodgkin lymphoma. |
FOXP1 |
| 65 |
25267198 |
10.1182/blood-2014-01-553412 |
2015 |
FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells. |
FOXP1 |
| 66 |
25541152 |
10.1038/leu.2014.351 |
2015 |
MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. |
FOXP1 |
| 67 |
25687653 |
10.1038/leu.2015.43 |
2015 |
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma. |
FOXP1 |
| 68 |
25691468 |
10.1101/gad.255331.114 |
2015 |
The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis. |
FOXP1 |
| 69 |
25712539 |
10.1002/path.4522 |
2015 |
Recurrent genomic rearrangements in primary testicular lymphoma. |
FOXP1 |
| 70 |
25828391 |
10.1097/PAS.0000000000000434 |
2015 |
Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases. |
FOXP1 |
| 71 |
23884370 |
10.1038/leu.2013.224 |
2014 |
Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients. |
FOXP1 |
| 72 |
24103868 |
10.3760/cma.j.issn.0253-2727.2013.09.001 |
2014 |
[The clinical characteristics and prognostic analysis of 147 cases of diffuse large B-cell lymphoma]. |
FOXP1 |
| 73 |
24117687 |
10.1111/his.12223 |
2014 |
Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients. |
FOXP1 |
| 74 |
24122791 |
10.1158/1078-0432.CCR-13-1482 |
2014 |
Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies. |
FOXP1 |
| 75 |
24366360 |
10.1182/blood-2013-09-525808 |
2014 |
The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. |
FOXP1 |
| 76 |
24416450 |
10.1371/journal.pone.0085851 |
2014 |
Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1. |
FOXP1 |
| 77 |
24805861 |
10.1097/PAS.0000000000000225 |
2014 |
Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases. |
FOXP1 |
| 78 |
25275049 |
|
2014 |
Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment. |
FOXP1 |
| 79 |
22368156 |
10.1002/hed.22928 |
2013 |
Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center. |
FOXP1 |
| 80 |
22736042 |
10.1007/s12032-012-0288-7 |
2013 |
Expression of FOXP1 in mucosa-associated lymphoid tissue lymphoma suggests a large tumor cell transformation and predicts a poorer prognosis in the positive thyroid patients. |
FOXP1 |
| 81 |
22780928 |
10.3760/cma.j.issn.0253-3766.2012.02.007 |
2013 |
[Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system]. |
FOXP1 |
| 82 |
22809882 |
10.1016/j.acthis.2012.06.001 |
2013 |
Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China. |
FOXP1 |
| 83 |
23022474 |
10.1016/j.canlet.2012.09.017 |
2013 |
Cancer genetics and genomics of human FOX family genes. |
FOXP1 |
| 84 |
23134861 |
|
2013 |
[Expression of FOXP1 and cyclinE in primary central nervous system lymphoma and its significance]. |
FOXP1 |
| 85 |
23382691 |
10.1371/journal.pgen.1003225 |
2013 |
Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. |
FOXP1 |
| 86 |
23384897 |
|
2013 |
[The clinical significance of a new classification algorithm in Chinese DLBCL cases]. |
FOXP1 |
| 87 |
23422111 |
|
2013 |
Prognostic value of clinical characteristics and immunophenotypic biomarkers in 115 patients with primary central nervous system lymphoma. |
FOXP1 |
| 88 |
23580662 |
10.1182/blood-2012-10-462846 |
2013 |
Downregulation of FOXP1 is required during germinal center B-cell function. |
FOXP1 |
| 89 |
21816504 |
10.1016/j.jaad.2011.03.031 |
2012 |
Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features. |
FOXP1 |
| 90 |
21934230 |
10.4103/0377-4929.85104 |
2012 |
Primary cardiac diffuse large B-cell lymphoma with activated B-cell-like phenotype. |
FOXP1 |
| 91 |
22009820 |
10.1002/hon.1017 |
2012 |
Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation. |
FOXP1 |
| 92 |
22372580 |
10.1111/j.1365-2559.2012.04179.x |
2012 |
Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma staining. |
FOXP1 |
| 93 |
22401769 |
10.1016/j.humpath.2011.10.013 |
2012 |
Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified. |
FOXP1 |
| 94 |
22437443 |
10.1038/leu.2012.83 |
2012 |
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. |
FOXP1 |
| 95 |
22503694 |
10.1016/j.ajo.2012.01.021 |
2012 |
Diffuse large B-cell lymphoma of the orbit: clinicopathologic, immunohistochemical, and prognostic features of 20 cases. |
FOXP1 |
| 96 |
19455257 |
|
2011 |
Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. |
FOXP1 |
| 97 |
20654154 |
|
2011 |
[Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China]. |
FOXP1 |
| 98 |
20830719 |
10.1002/ijc.25663 |
2011 |
BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. |
FOXP1 |
| 99 |
20854073 |
10.3109/00313025.2010.508786 |
2011 |
Primary central nervous system lymphoma: a clinicopathological study of 75 cases. |
FOXP1 |
| 100 |
21055028 |
|
2011 |
[Study on genetic aberrations of ocular mucosa-associated lymphoid tissue lymphomas occurring in southern China]. |
FOXP1 |
Datasets
Models
